Connecticut Children's Medical Center is a nationally ranked, independent, non-profit, pediatric acute care hospital located in Hartford, Connecticut.

There are 185 beds in Connecticut Children's Medical Center.

During the past decade, Connecticut Children's Medical Center conducted 140 clinical trials. In the 10-year time frame, 140 clinical trials started and 121 clinical trials were completed, i.e. on average, 86.4% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 54 clinical trials were completed. i.e. 93.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Connecticut Children's Medical Center" #1 sponsor was "Children's Oncology Group" with 96 trials, followed by "National Cancer Institute (NCI)" with 46 trials sponsored, "Connecticut Children's Medical Center" with 33 trials sponsored, "Wake Forest University Health Sciences" with 14 trials sponsored and "Bristol-Myers Squibb" with 14 trials sponsored. Other sponsors include 120 different institutions and companies that sponsored additional 76 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Connecticut Children's Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 102 trials as a collaborator, "Connecticut Children's Medical Center" with 10 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 8 trials as a collaborator, "Boston Children's Hospital" with 6 trials as a collaborator and "Beat NB Cancer Foundation" with 5 trials as a collaborator. Other collaborators include 263 different institutions and companies that were collaborators in the rest 184 trials.

According to Clinical.Site data, the most researched conditions in "Connecticut Children's Medical Center" are "Neuroblastoma" (21 trials), "Acute Lymphoblastic Leukemia" (13 trials), "Recurrent Neuroblastoma" (12 trials), "Recurrent Osteosarcoma" (12 trials) and "Rhabdomyosarcoma" (11 trials). Many other conditions were trialed in "Connecticut Children's Medical Center" in a lesser frequency.

Most popular intervention types in "Connecticut Children's Medical Center" are "Drug" (203 trials), "Other" (121 trials), "Procedure" (68 trials), "Biological" (65 trials) and "Radiation" (46 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (61 trials), "Cyclophosphamide" (48 trials), "Vincristine Sulfate" (39 trials), "Etoposide" (32 trials) and "Doxorubicin Hydrochloride" (29 trials). Other intervention names were less common.

The vast majority of trials in "Connecticut Children's Medical Center" are 314 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are 149 active trials in "Connecticut Children's Medical Center". 1 are not yet recruiting, 73 are recruiting, 73 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 152 completed trials in Connecticut Children's Medical Center, 3 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Connecticut Children's Medical Center, 23 "Phase 1" clinical trials were conducted, 98 "Phase 2" clinical trials and 109 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 34 trials that are defined as “Not Applicable".

Connecticut Children's Medical Center has several departments that took part in Clinical trials: "Connecticut Children's Medical Center" - 14 trials, "Connecticut Children's Med Ctr - Pediatric" - 5 trials, "Connecticut Children's Medical Center -Pharmacy" - 2 trials, "Connecticut Children's Medical Center; 5E Clinical Trials Unit" - 2 trials